David McIntosh: Heart-warming and Life-saving! Sky’s Contribution is Enormously Important
David McIntosh, Founder and Chair of United Plasma Action, reposted from NHS Blood and Transplant on LinkedIn:
”Heart-warming AND life-saving!!
Sky’s contribution is enormously important.
Are all the other Media companies doing similar things?
Are all UK employers with large high-employment sites welcoming cooperation with their local Blood Transfusion Services??
If not, why not ???? ????”
NHS Blood and Transplant shared on LinkedIn:
”Proving the Sky really is the limit when it comes to generosity!
We were delighted to team up once again with Sky at the start of September, hosting ‘What’s Your Blood Type?’ events at the company’s Isleworth office.
Over two days, we had the pleasure of meeting more than 1,500 members of staff, many of whom discovered their blood types and how their donations could be used to save lives.
The results were fantastic:
- 155 Sky colleagues signed up to become plasma donors
- 85 registered to become blood donors
- 72 appointments already booked
We’re proud to have partnered with Sky over the last two years, helping us reach new donors and raise awareness.
Huge thanks to our champion Bayley Thomas at Sky, who’s been brilliant in supporting these events.
Bayley says: “At Sky, we’re incredibly proud of our partnership with NHS Blood and Transplant.
Through the What’s Your Blood Type? events, we’ve not only raised awareness of the vital need for blood and plasma donations and shone a light on conditions like sickle cell, but also inspired action.”
Aditya Raj, our Plasma Engagement Manager, adds: “We’re hugely thankful to have the continued support of Sky.
This month’s event was our third with the company, with each delivering huge enthusiasm and registration numbers among staff.”
To everyone at Sky who joined us, asked questions, registered, and booked appointments – you’re absolute stars!”
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin